Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
2020 · New England Journal of Medicine · 924 citations
https://doi.org/10.1056/nejmoa1905239
M
Michael D. Shapiro
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
533
Papers
15.6K
Citations
63
h-index
195
i10-index
Michael D. Shapiro is an academic researcher from Wake Forest University. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Cardiac Imaging and Diagnostics & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 63, co-authored 454 publications.
ORCID: 0000-0002-9071-3287Papers by this author
worksThe Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
2018 · Endocrine Reviews · 563 citations
https://doi.org/10.1210/er.2018-00184
Global burden of metabolic diseases, 1990–2021
2024 · Metabolism · 260 citations
https://doi.org/10.1016/j.metabol.2024.155999
Ten things to know about ten cardiovascular disease risk factors
2021 · American Journal of Preventive Cardiology · 241 citations
https://doi.org/10.1016/j.ajpc.2021.100149
Dynamic Patterns of Retinoic Acid Synthesis and Response in the Developing Mammalian Heart
1998 · Developmental Biology · 228 citations
https://doi.org/10.1006/dbio.1998.8911
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology
2020 · American Journal of Preventive Cardiology · 147 citations
https://doi.org/10.1016/j.ajpc.2020.100009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat